Colloque HUG ¦ Lymphome T cutané - Dre Begonia Cortes Sanchez

This presentation explores cutaneous T-cell lymphomas, with a focus on mycosis fungoides and Sézary syndrome, their diagnostic challenges, and recent therapeutic advances. Through a clinical case, this lecture addresses the pathophysiology, diagnostic criteria, current and innovative treatments, as well as the role of allogeneic transplantation and new immunotherapies in advanced stages. Chapters: 00:00 Introduction and initial clinical case 00:27 Clinical presentation of mycosis fungoides 01:53 Definition and epidemiology of cutaneous T-cell lymphomas 02:18 Clinical manifestations and variants of mycosis fungoides 04:38 Sézary syndrome: diagnosis and blood involvement 05:26 Pathophysiology and tumor microenvironment 06:54 Staging, prognosis, and progression factors 08:49 Treatments of early stages and chlormethine gel 12:02 Immunotherapies, allogeneic transplantation, and new molecules 22:08 Diagnostic pitfalls and the link between dupilumab and lymphoma #CutaneousLymphoma #MycosisFongoides #SézarySyndrome #Dermatology #Hematology #Immunotherapy #Oncology #Dermatopathology #Dupilumab #Medicine

HUG Symposium | FLASH: New Therapeutic Avenues in Bronchiectasis - Dr. Ivana Besenji
▶︎

HUG Symposium | FLASH: New Therapeutic Avenues in Bronchiectasis - Dr. Ivana Besenji

HUG Symposium | Multidrug-resistant Gram-negative bacteria - Dr. Diego Andrey
▶︎

HUG Symposium | Multidrug-resistant Gram-negative bacteria - Dr. Diego Andrey

Hôpital de La Tour ¦ Quand l’urine voit rouge : stratégie face à l’hématurie - Dr Vanessa Fenner
▶︎

Hôpital de La Tour ¦ Quand l’urine voit rouge : stratégie face à l’hématurie - Dr Vanessa Fenner

Lymphomes et maladie de Hodgkin : C la Santé
▶︎

Lymphomes et maladie de Hodgkin : C la Santé

Leukemias: Pathology review
▶︎

Leukemias: Pathology review

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

Narcissistic Abusers: Understanding and Protecting Yourself - A Dialogue with Anne-Clotilde Ziégler
▶︎

Narcissistic Abusers: Understanding and Protecting Yourself - A Dialogue with Anne-Clotilde Ziégler

The French Do Not Care About Work
▶︎

The French Do Not Care About Work

Maïtena Biraben témoigne sans filtre sur son autisme, son TDAH et son HPI
▶︎

Maïtena Biraben témoigne sans filtre sur son autisme, son TDAH et son HPI

Pardon et confiance dans les relations - Teach! - Athoms Mbuma
▶︎

Pardon et confiance dans les relations - Teach! - Athoms Mbuma

Medical Day #11 | Outpatient Management of TIA - Prof. Emmanuel Carrera
▶︎

Medical Day #11 | Outpatient Management of TIA - Prof. Emmanuel Carrera

Colloque HUG ¦ Médecine et environnement - Mme Da Ernestho Crespin, Pre Sommer, Pr Jackson
▶︎

Colloque HUG ¦ Médecine et environnement - Mme Da Ernestho Crespin, Pre Sommer, Pr Jackson

JHaS | Asthma in Children - Dr. Isabelle Ruchonnet-Métrailler
▶︎

JHaS | Asthma in Children - Dr. Isabelle Ruchonnet-Métrailler

Living With A Pacemaker (common questions answered) - in Plain English!
▶︎

Living With A Pacemaker (common questions answered) - in Plain English!

FIFA World Cup Uncut | 8 Minutes of Unforgettable Madness | Brazil vs Germany (2014 Semi-Final)
▶︎

FIFA World Cup Uncut | 8 Minutes of Unforgettable Madness | Brazil vs Germany (2014 Semi-Final)

How does immunotherapy work? A brief comparison to chemotherapy.
▶︎

How does immunotherapy work? A brief comparison to chemotherapy.

Why EDS is more than "just loose joints" | (MIS)Treated
▶︎

Why EDS is more than "just loose joints" | (MIS)Treated

Everyone Has Already Boosted Their Ferritin – Why Haven't You?
▶︎

Everyone Has Already Boosted Their Ferritin – Why Haven't You?

Medical Day #11 | The Role of AI in the Practice - Dr. Mayssam Nehme
▶︎

Medical Day #11 | The Role of AI in the Practice - Dr. Mayssam Nehme

A Coag Conversation: 100 Years of Von Willebrand Disease & Upcoming Advances - Part 1
▶︎

A Coag Conversation: 100 Years of Von Willebrand Disease & Upcoming Advances - Part 1